TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35106632

Group type: EXPERIMENTAL
Intervention: Cystine and glutamine supplementation
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 33271633

Group type: EXPERIMENTAL
Intervention: Dexcom G6 continuous glucose monitoring (CGM)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Standard care with a glucometer (control)
Number of subjects: 14
Study: 34098409

Group type: EXPERIMENTAL
Intervention: Imagery-based cognitive behavioural intervention (ICBI)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Non-directive supportive therapy (NDST)
Number of subjects: 56
Study: 32549100

Group type: EXPERIMENTAL
Intervention: Topical lidocaine group (10% lidocaine oropharyngeal spray, five minutes before laryngoscopy and endotracheal intubation)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (no lidocaine spray)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 60
Study: 35114983

Group type: EXPERIMENTAL
Intervention: Supported Osteoarthritis Self‐management Program (SOASP) with self‐monitoring physical activity using a commercial wearable activity tracker (WAT) for 12 weeks, n = 86
Number of subjects: 160

Group type: COMPARATOR
Intervention: Only the Supported Osteoarthritis Self‐management Program (SOASP) for 12 weeks, n = 74
Number of subjects: 160
Study: 33216632

Group type: EXPERIMENTAL
Intervention: Korean Red Ginseng (3 g per day for 12 weeks)
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo (for 12 weeks)
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Korean Red Ginseng
Number of subjects: 55
Study: 32680803

Group type: EXPERIMENTAL
Intervention: Therapeutic singing
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: General singing
Number of subjects: 54

Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 54
Study: 33197648

Group type: EXPERIMENTAL
Intervention: Individualized coaching program at home (EG)
Number of subjects: 83

Group type: COMPARATOR
Intervention: Usual care control (CG)
Number of subjects: 83
Study: 34057279

Group type: EXPERIMENTAL
Intervention: MNM covering stent (MNM group, n = 25)
Number of subjects: 52

Group type: COMPARATOR
Intervention: Any commercially available stent (DES group, n = 27)
Number of subjects: 52
Study: 36297060

Group type: EXPERIMENTAL
Intervention: Ketone monoester supplement (KME) 25 g
Number of subjects: 9

Group type: COMPARATOR
Intervention: Non‐caloric placebo (PLAC)
Number of subjects: 9
Study: 33865741

Group type: EXPERIMENTAL
Intervention: Pre-procedural IVUS-based regression model
Number of subjects: 618

Group type: EXPERIMENTAL
Intervention: Convolutional neural network and mask image-derived features
Number of subjects: 618
Study: 34216477

Group type: EXPERIMENTAL
Intervention: Intermittent-Scanning Continuous Glucose Monitoring (isCGM) combined with structured education
Number of subjects: 104

Group type: COMPARATOR
Intervention: Conventional self-monitoring of blood glucose (SMBG)
Number of subjects: 104
Study: 35294320

Group type: EXPERIMENTAL
Intervention: Low-volume high-intensity interval training (LV-HIIT) sessions (10 x 60 s at 100% of Vmax)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Low-volume high-intensity interval training (LV-HIIT) sessions (20 x 30 s at 100% of Vmax)
Number of subjects: 24
Study: 32342648

Group type: EXPERIMENTAL
Intervention: LIGHT (20–30 repetition maximum)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: HEAVY (6–10 repetition maximum)
Number of subjects: 26

Group type: COMPARATOR
Intervention: LIGHT and HEAVY training programs
Number of subjects: 26
Study: 34750146

Group type: EXPERIMENTAL
Intervention: 81 mg ASA
Number of subjects: 95

Group type: EXPERIMENTAL
Intervention: 325 mg ASA
Number of subjects: 95

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 95
Study: 33813863

Group type: COMPARATOR
Intervention: Control arm patients with follow-up imaging at 2-8 hours without substantial recanalization and baseline Alberta Stroke Program Early CT Score ≥9
Number of subjects: 43
Study: 33894540

Group type: EXPERIMENTAL
Intervention: Pythagorean Self‐Awareness Intervention (PSAI) with usual care
Number of subjects: 69

Group type: COMPARATOR
Intervention: Usual care only
Number of subjects: 69
Study: 34766577

Group type: EXPERIMENTAL
Intervention: Spine journal
Number of subjects: 3784

Group type: COMPARATOR
Intervention: European Spinal Journal (EUS)
Number of subjects: 3784

Group type: COMPARATOR
Intervention: The Spine Journal (TSJ)
Number of subjects: 3784

Group type: COMPARATOR
Intervention: Journal of Neurosurgery ‐ Spine (JNS spine)
Number of subjects: 3784

Group type: EXPERIMENTAL
Intervention: Corresponding authors with orthopedic specialties
Number of subjects: 3784

Group type: COMPARATOR
Intervention: Corresponding authors who were neurosurgeons
Number of subjects: 3784

Group type: EXPERIMENTAL
Intervention: Single institution articles
Number of subjects: 3784

Group type: EXPERIMENTAL
Intervention: Degenerative diseases
Number of subjects: 3784

Group type: EXPERIMENTAL
Intervention: Clinical articles
Number of subjects: 3784

Group type: EXPERIMENTAL
Intervention: Meta-analyses and randomized controlled comparative studies
Number of subjects: 3784
Study: 32471514

Group type: EXPERIMENTAL
Intervention: Independent pharmacist prescribing (PIP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 0
Study: 616063492

Group type: EXPERIMENTAL
Intervention: Ipsilateral breast tumour recurrence (IBTR)
Number of subjects: 1975

Group type: EXPERIMENTAL
Intervention: ER-negative cohort
Number of subjects: 1975

Group type: EXPERIMENTAL
Intervention: ER-positive cohort
Number of subjects: 1975

Group type: EXPERIMENTAL
Intervention: Primary tumor characteristics (T size, nodal status)
Number of subjects: 1975
Study: 36018753

Group type: EXPERIMENTAL
Intervention: Dendritic cell vaccines with 0.10, 0.33, or 1.0 µg of recombinant SARS-CoV-2 spike protein, with or without GM-CSF
Number of subjects: 176

Group type: EXPERIMENTAL
Intervention: Dendritic cell vaccines without GM-CSF
Number of subjects: 176
Study: 34219257

Group type: EXPERIMENTAL
Intervention: Calcium and vitamin D1–25 supplementation for high-risk patients, routine daily calcium samples until 48 hours post-surgery.
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Routine daily calcium samples for low-risk patients until 48 hours post-surgery.
Number of subjects: 66

Group type: COMPARATOR
Intervention: Historical control group treated only if they presented hypocalcemia.
Number of subjects: 66
Study: 32371123

Group type: EXPERIMENTAL
Intervention: Standard chemotherapy with rituximab
Number of subjects: 160

Group type: COMPARATOR
Intervention: Standard chemotherapy without rituximab (Control)
Number of subjects: 160

Group type: EXPERIMENTAL
Intervention: Whole brain radiotherapy (WBRT)
Number of subjects: 160
Study: 35671553

Group type: EXPERIMENTAL
Intervention: Very Low Nicotine Content (VLNC) cigarettes (0.4 mg/g nicotine)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Normal Nicotine Content (NNC) cigarettes (15.8 mg nicotine/g tobacco)
Number of subjects: 58
Study: 32607574

Group type: EXPERIMENTAL
Intervention: Severe delirium
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: 5 or more days of delirium or coma
Number of subjects: 434

Group type: EXPERIMENTAL
Intervention: Delirium severity and number of days of delirium or coma
Number of subjects: 434
Study: 33141624

Group type: EXPERIMENTAL
Intervention: Bilingual speakers with PD
Number of subjects: 11

Group type: COMPARATOR
Intervention: Bilingual controls
Number of subjects: 11

Group type: COMPARATOR
Intervention: Native English speakers
Number of subjects: 11
Study: 36471412

Group type: EXPERIMENTAL
Intervention: NIKA (Nederlandse Interventie Kortdurend op Atypisch oudergedrag)
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: EMDR therapy
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Combination of NIKA and EMDR
Number of subjects: 150

Group type: COMPARATOR
Intervention: Waitlist usual care group (control)
Number of subjects: 150
Study: 32785726

Group type: EXPERIMENTAL
Intervention: Mix-and-match implantation of a diffractive extended depth of focus IOL (TECNIS Symfony ZXR00) and a diffractive bifocal IOL (TECNIS ZLB00 +3.25 diopters)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Bilateral implantation of a diffractive trifocal IOL (AcrySof IQ PanOptix)
Number of subjects: 50
Study: 36428095

Group type: COMPARATOR
Intervention: Control messaging
Number of subjects: 2222

Group type: EXPERIMENTAL
Intervention: Reduced risk messaging
Number of subjects: 2222

Group type: EXPERIMENTAL
Intervention: FDA endorsement message
Number of subjects: 2222
Study: 33911087

Group type: EXPERIMENTAL
Intervention: multimodal intervention (diet, physical activity, psychosocial support)
Number of subjects: 342

Group type: COMPARATOR
Intervention: lifestyle recommendations (control group)
Number of subjects: 342
Study: 34937780

Group type: EXPERIMENTAL
Intervention: Presence of cerebral microbleeds (CMBs)
Number of subjects: 466

Group type: COMPARATOR
Intervention: No cerebral microbleeds (CMBs)
Number of subjects: 466
Study: 34454119

Group type: EXPERIMENTAL
Intervention: Bedaquiline-containing regimen
Number of subjects: 103

Group type: COMPARATOR
Intervention: Bedaquiline-free regimen
Number of subjects: 103

Group type: EXPERIMENTAL
Intervention: Both regimens
Number of subjects: 103
Study: 36007171

Group type: EXPERIMENTAL
Intervention: Vitrectomy and gas tamponade
Number of subjects: 262

Group type: EXPERIMENTAL
Intervention: D chart distortion scores
Number of subjects: 262
Study: 34903194

Group type: EXPERIMENTAL
Intervention: Bright light intensity setting
Number of subjects: 50

Group type: COMPARATOR
Intervention: Medium light intensity setting
Number of subjects: 50

Group type: COMPARATOR
Intervention: Dark light intensity setting
Number of subjects: 50
Study: 33492271

Group type: EXPERIMENTAL
Intervention: Dynamic stretching (DS)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Heavy load leg press (HL)
Number of subjects: 26
Study: 33023423

Group type: EXPERIMENTAL
Intervention: Tenecteplase
Number of subjects: 202

Group type: COMPARATOR
Intervention: Alteplase
Number of subjects: 202
Study: 35411784

Group type: EXPERIMENTAL
Intervention: Nomogram model for predicting postoperative headache (POH)
Number of subjects: 13440
Study: 33036645

Group type: EXPERIMENTAL
Intervention: Breast milk oral stimulation
Number of subjects: 69

Group type: EXPERIMENTAL
Intervention: Physiological saline oral stimulation
Number of subjects: 69

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 69
Study: 34166587

Group type: EXPERIMENTAL
Intervention: DR/ER-MPH (Delayed-release and extended-release methylphenidate)
Number of subjects: 0
Study: 32414958

Group type: EXPERIMENTAL
Intervention: PsA with systemic lupus erythematosus (SLE)
Number of subjects: 4836

Group type: COMPARATOR
Intervention: Control group (general population)
Number of subjects: 4836

Group type: EXPERIMENTAL
Intervention: PsA patients
Number of subjects: 4836
Study: 33290616

Group type: EXPERIMENTAL
Intervention: PF-06826647 (doses: 3, 10, 30, 100, 200, 400, or 1,600 mg for SAD; 30, 100, 400, or 1,200 mg q.d. or 200 mg b.i.d. for 10 days for MAD)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 33186199

Group type: EXPERIMENTAL
Intervention: Automated detection of exercise sessions using an algorithm
Number of subjects: 54

Group type: EXPERIMENTAL
Intervention: Algorithm-detected exercise sessions (total and intensity)
Number of subjects: 54
Study: 616269767

Group type: EXPERIMENTAL
Intervention: Higher education, income, and socioeconomic status (SES)
Number of subjects: 4161

Group type: EXPERIMENTAL
Intervention: SCORE algorithm for higher risk countries
Number of subjects: 4161
Study: 35440611

Group type: EXPERIMENTAL
Intervention: Indomethacin
Number of subjects: 210

Group type: COMPARATOR
Intervention: Paracetamol (Control)
Number of subjects: 210
Study: 32947603

Group type: EXPERIMENTAL
Intervention: B. breve BBG‐001
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control (not specified)
Number of subjects: 94
Study: 32380069

Group type: EXPERIMENTAL
Intervention: Azithromycin 250 mg or 500 mg, three times a week for 6 months
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo, three times a week for 6 months
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Azithromycin
Number of subjects: 90
Study: 35858170

Group type: EXPERIMENTAL
Intervention: Intensive follow-up regimen (INT)
Number of subjects: 1871

Group type: COMPARATOR
Intervention: Minimalist follow-up regimen (MIN)
Number of subjects: 1871
Study: 34738518

Group type: EXPERIMENTAL
Intervention: 3-day amoxicillin treatment
Number of subjects: 824

Group type: EXPERIMENTAL
Intervention: 7-day amoxicillin treatment
Number of subjects: 824

Group type: EXPERIMENTAL
Intervention: Lower dose (35-50 mg/kg/day)
Number of subjects: 824

Group type: EXPERIMENTAL
Intervention: Higher dose (70-90 mg/kg/day)
Number of subjects: 824

Group type: EXPERIMENTAL
Intervention: 7-day treatment
Number of subjects: 824

Group type: COMPARATOR
Intervention: 3-day treatment
Number of subjects: 824

Group type: EXPERIMENTAL
Intervention: Both doses and durations
Number of subjects: 824
Study: 35813410

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle massage
Number of subjects: 120

Group type: COMPARATOR
Intervention: Control group (estradiol valerate and progesterone without pelvic floor muscle massage)
Number of subjects: 120
Study: 34547084

Group type: EXPERIMENTAL
Intervention: School-wide IPM program
Number of subjects: 236

Group type: COMPARATOR
Intervention: Sham HEPA filter purifiers
Number of subjects: 236

Group type: EXPERIMENTAL
Intervention: Classroom HEPA filter purifiers
Number of subjects: 236

Group type: COMPARATOR
Intervention: No IPM
Number of subjects: 236
Study: 32962487

Group type: EXPERIMENTAL
Intervention: Ranibizumab plus fufang xueshuantong capsule (cFXST)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Ranibizumab alone
Number of subjects: 38
Study: 34535610

Group type: EXPERIMENTAL
Intervention: Topical clindamycin 1% solution combined with LAight® therapy (8 bi-weekly treatments)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Topical clindamycin 1% solution only
Number of subjects: 81
Study: 32746749

Group type: EXPERIMENTAL
Intervention: Genetically predicted TSH levels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Genetically predicted BMI
Number of subjects: 0
Study: 33802651

Group type: EXPERIMENTAL
Intervention: Ketogenic Diet with Placebo (KD + PL)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Ketogenic Diet with Ketone Supplement (KD + KS)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low-Fat Diet (LFD)
Number of subjects: 12
Study: 33036554

Group type: EXPERIMENTAL
Intervention: Continuous adductor canal block at the proximal end
Number of subjects: 62

Group type: COMPARATOR
Intervention: Continuous adductor canal block at the middle of the canal
Number of subjects: 62
Study: 34984477

Group type: EXPERIMENTAL
Intervention: Ropivacaine
Number of subjects: 96

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 96
Study: 34416788

Group type: EXPERIMENTAL
Intervention: Focal laser therapy (micropulse laser or argon laser coagulation) for treating leakage points visible in fluorescein angiography (FA)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Photodynamic therapy (PDT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Systemic administration of mineralocorticoid receptor antagonists, carbonic anhydrase inhibitors, or non-steroidal anti-inflammatory drugs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Anti-VEGF treatment
Number of subjects: 0
Study: 33207606

Group type: EXPERIMENTAL
Intervention: Beetroot powder providing 200 mg nitrate
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Beetroot with 0.8 g of L-arginine
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Beetroot with 1.5 g of L-arginine
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Beetroot with 3.0 g of L-arginine
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control meal (without beetroot)
Number of subjects: 18
Study: 35337274

Group type: EXPERIMENTAL
Intervention: Lenvatinib
Number of subjects: 132

Group type: COMPARATOR
Intervention: Sorafenib
Number of subjects: 132
Study: 34587703

Group type: EXPERIMENTAL
Intervention: Preload of low-intensity-cooked yam paste (10 g) before rice meal
Number of subjects: 18

Group type: COMPARATOR
Intervention: Coingested low-intensity-cooked yam paste with rice
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Preload of medium-intensity-cooked yam paste before rice meal
Number of subjects: 18

Group type: COMPARATOR
Intervention: Coingested medium-intensity-cooked yam paste with rice
Number of subjects: 18
Study: 35951113

Group type: EXPERIMENTAL
Intervention: Active rTMS
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 30
Study: 33591858

Group type: EXPERIMENTAL
Intervention: Whey protein (20/10/3 g)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo (30/3 g)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Exercise training
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Whey protein
Number of subjects: 24
Study: 32836016

Group type: EXPERIMENTAL
Intervention: Exosomal TDP‐43 ratio
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Neurofilament light chain (NFL)
Number of subjects: 18

Group type: EXPERIMENTAL
Intervention: Phosphorylated neurofilament heavy chain (pNFH)
Number of subjects: 18
Study: 35085715

Group type: EXPERIMENTAL
Intervention: Inverse-planned intensity modulated radiation therapy
Number of subjects: 181

Group type: COMPARATOR
Intervention: Forward-planned intensity modulated radiation therapy
Number of subjects: 181

Group type: EXPERIMENTAL
Intervention: Maintaining the LV volume receiving 5 Gy and 10 Gy
Number of subjects: 181
Study: 35381737

Group type: EXPERIMENTAL
Intervention: Radiomics model based on multi-phase CT images (P + A + V)
Number of subjects: 195

Group type: EXPERIMENTAL
Intervention: Radiomics model including CT reports of LNM
Number of subjects: 195
Study: 35777031

Group type: EXPERIMENTAL
Intervention: Laparoscopic TEP inguinal hernia repair (group A)
Number of subjects: 174

Group type: COMPARATOR
Intervention: Lichtenstein tension-free mesh repair (group B)
Number of subjects: 174
Study: 35234673

Group type: EXPERIMENTAL
Intervention: Nesvacumab 3 mg + aflibercept 2 mg (LD combo)
Number of subjects: 302

Group type: EXPERIMENTAL
Intervention: Nesvacumab 6 mg + aflibercept 2 mg (HD combo)
Number of subjects: 302

Group type: COMPARATOR
Intervention: Intravitreal aflibercept injection (IAI) 2 mg
Number of subjects: 302
Study: 33197396

Group type: EXPERIMENTAL
Intervention: Early ECMO‐facilitated resuscitation
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard ACLS treatment
Number of subjects: 30
Study: 36198470

Group type: EXPERIMENTAL
Intervention: Person-centred support programme (RESPECT intervention)
Number of subjects: 41

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 41
Study: 32961334

Group type: EXPERIMENTAL
Intervention: Atrial arrhythmias
Number of subjects: 4028

Group type: COMPARATOR
Intervention: No atrial arrhythmias
Number of subjects: 4028
Study: 34355327

Group type: EXPERIMENTAL
Intervention: Indigenous ecological knowledge (IEK) based management of ecosystem services (ESs)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Socio-demographic attributes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Indigenous ecological belief systems
Number of subjects: 0
Study: 33878461

Group type: EXPERIMENTAL
Intervention: Interferon α‐2b spray
Number of subjects: 668

Group type: COMPARATOR
Intervention: Ribavirin Aerosol
Number of subjects: 668
Study: 36434768

Group type: EXPERIMENTAL
Intervention: LIPA breaks (5-minute walk every 25 minutes)
Number of subjects: 21

Group type: EXPERIMENTAL
Intervention: Cognitively demanding activities (COGN)
Number of subjects: 21

Group type: COMPARATOR
Intervention: LIPA breaks (INTERRUPT)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sitting without a demanding cognitive task (SIT)
Number of subjects: 21

Group type: COMPARATOR
Intervention: Sitting with a demanding cognitive task (COGN)
Number of subjects: 21
Study: 35010877

Group type: EXPERIMENTAL
Intervention: Cocoa powder
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Red berries mixture
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combination of cocoa and red berries
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 60
Study: 35853271

Group type: EXPERIMENTAL
Intervention: Cervicovaginal fetal fibronectin (qfFN) concentration with Arabin pessary in situ
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cervicovaginal fetal fibronectin (qfFN) concentration without Arabin pessary
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cervical length (CL) measurement without Arabin pessary
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cervical length (CL) measurement with Arabin pessary in situ
Number of subjects: 0
Study: 32070406

Group type: EXPERIMENTAL
Intervention: Robotic arm-assisted functionally aligned TKA (FA TKA)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Robotic arm-assisted mechanically aligned TKA (MA TKA)
Number of subjects: 100
Study: 35878179

Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BoNT‐A)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Saline solution (placebo control group)
Number of subjects: 80
Study: 33704047

Group type: EXPERIMENTAL
Intervention: Iron deficiency anemia (IDA) with restless legs syndrome (RLS)
Number of subjects: 124

Group type: EXPERIMENTAL
Intervention: Iron deficiency anemia (IDA) without restless legs syndrome (RLS)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Idiopathic restless legs syndrome (RLS)
Number of subjects: 124
Study: 36174817

Group type: EXPERIMENTAL
Intervention: SCR BT
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: SCR HD
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: SCR BT and SCR HD
Number of subjects: 53
Study: 33791945

Group type: EXPERIMENTAL
Intervention: Siponimod
Number of subjects: 0

Group type: COMPARATOR
Intervention: Interferon beta‐1a
Number of subjects: 0
Study: 32720113

Group type: EXPERIMENTAL
Intervention: Diarrhoea Management Diary (DMD)
Number of subjects: 62
Study: 35014156

Group type: EXPERIMENTAL
Intervention: AZD4017
Number of subjects: 93

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 93
Study: 34289889

Group type: EXPERIMENTAL
Intervention: Hemostatic agent
Number of subjects: 90

Group type: COMPARATOR
Intervention: Suturing
Number of subjects: 90
Study: 35510397

Group type: EXPERIMENTAL
Intervention: Transportation to thrombectomy-capable center
Number of subjects: 1401

Group type: COMPARATOR
Intervention: Transportation to local stroke center
Number of subjects: 1401
Study: 33226542

Group type: EXPERIMENTAL
Intervention: Knee Control IPEP
Number of subjects: 47

Group type: EXPERIMENTAL
Intervention: Knee Control+ IPEP
Number of subjects: 47
Study: 33556574

Group type: EXPERIMENTAL
Intervention: NBD-modified peptides selected from a phage library
Number of subjects: 0